David Erlinge

31.9k total citations · 3 hit papers
455 papers, 13.8k citations indexed

About

David Erlinge is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, David Erlinge has authored 455 papers receiving a total of 13.8k indexed citations (citations by other indexed papers that have themselves been cited), including 287 papers in Cardiology and Cardiovascular Medicine, 125 papers in Surgery and 111 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in David Erlinge's work include Acute Myocardial Infarction Research (140 papers), Cardiac Imaging and Diagnostics (108 papers) and Antiplatelet Therapy and Cardiovascular Diseases (87 papers). David Erlinge is often cited by papers focused on Acute Myocardial Infarction Research (140 papers), Cardiac Imaging and Diagnostics (108 papers) and Antiplatelet Therapy and Cardiovascular Diseases (87 papers). David Erlinge collaborates with scholars based in Sweden, United States and Denmark. David Erlinge's co-authors include Stefan James, Tomas Jernberg, Matthias Götberg, Lars Edvinsson, Olof Gidlöf, Oscar Ö. Braun, Bertil Lindahl, Sasha Koul, Lingwei Wang and Geoffrey Burnstock and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Circulation.

In The Last Decade

David Erlinge

431 papers receiving 13.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Medical Therapy for Secondary Prevention and Long-Term Outcome in Patients With Myocardial Infarction With Nonobstructive Coronary Artery Disease

2017 309 citations Bertil Lindahl, Tomasz Baron et al. Circulation profile →
Improved outcomes in patients with ST-elevation myocardial infarction during the last 20 years are related to implementation of evidence-based treatments: experiences from the SWEDEHEART registry 1995–2014

2017 276 citations Karolina Szummer, Joakim Alfredsson et al. European Heart Journal profile →
Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction

2024 99 citations Troels Yndigegn, Bertil Lindahl et al. profile →

Peers

Countries citing papers authored by David Erlinge

Since Specialization

Citations

This map shows the geographic impact of David Erlinge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Erlinge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Erlinge more than expected).

Fields of papers citing papers by David Erlinge

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Erlinge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Erlinge. The network helps show where David Erlinge may publish in the future.

Co-authorship network of co-authors of David Erlinge

This figure shows the co-authorship network connecting the top 25 collaborators of David Erlinge. A scholar is included among the top collaborators of David Erlinge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Erlinge. David Erlinge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Circulating protein biomarkers and their association with vulnerable plaque characteristics – a PROSPECT II substudy 2025 ·International Journal of Cardiology Cardiovascular Risk and Prevention ·(unknown), Akiko Maehara, Michael Mæng, Lars Kjøller‐Hansen, Thomas Engstrøm, Ori Ben‐Yehuda, Mitsuaki Matsumura, Ole Fröbert, Jonas Persson, Rune Wiseth, Alf Inge Larsen, Sasha Koul, Rebecca Rylance, Gary S. Mintz, Ziad A. Ali, Stefan James, Gregg W. Stone, David Erlinge	2
2	Deferral of left main coronary artery revascularization via IVUS or coronary physiology - Long-term outcomes from the SWEDEHEART registry 2024 ·International Journal of Cardiology ·(unknown), Moman A. Mohammad, Sasha Koul, Troels Yndigegn, (unknown), (unknown), Rikard Linder, Sebastian Völz, Ole Fröbert, David Erlinge, Matthias Götberg	1
3	Importance of hospital and clinical factors for early mortality in Takotsubo syndrome: Insights from the Swedish Coronary Angiography and Angioplasty Registry 2024 ·BMC Cardiovascular Disorders ·(unknown), Björn Redfors, Truls Råmunddal, Oskar Angerås, Pétur Pétursson, Araz Rawshani, (unknown), Joakim Alfredsson, Christina Ekenbäck, Loghman Henareh, Kristofer Skoglund, Charlotta Ljungman, Moman A. Mohammad, Tomas Jernberg, Ole Fröbert, David Erlinge, Elmir Ömerovic	0
4	Abbreviated versus standard dual antiplatelet therapy time after PCI in high bleeding risk patients with acute coronary syndrome - a report from the SWEDEHEART registry 2023 ·European Heart Journal ·(unknown), Sasha Koul, Elmir Ömerovic, John Andersson, Stefan Agewall, Stefan James, Arash Mokhtari, Jesper van der Pals, Axel Wester, Karolina Szummer, Tomas Jernberg, David Erlinge, Moman A. Mohammad	1
5	Intracoronary Imaging of Proximal Coronary Artery Lesions – A Nationwide Lesion-Level Analysis From SCAAR 2023 ·Journal of the Society for Cardiovascular Angiography & Interventions ·(unknown), (unknown), Pontus Andell, Göran Olivecrona, Matthias Götberg, Elmir Ömerovic, Ole Fröbert, Sergio Buccheri, Stefan James, Sasha Koul, Moman A. Mohammad, David Erlinge	1
6	Design and rationale of randomized evaluation of decreased usage of beta-blockers after acute myocardial infarction (REDUCE-AMI) 2022 ·European Heart Journal - Cardiovascular Pharmacotherapy ·Troels Yndigegn, Bertil Lindahl, Joakim Alfredsson, Jocelyne Benatar, (unknown), David Erlinge, (unknown), Claes Held, Pelle Johansson, Patric Karlström, Thomas Kellerth, Toomas Marandi, (unknown), Annica Ravn‐Fischer, Johan Sundström, Ollie Östlund, Robin Hofmann, Tomas Jernberg	15
7	Assessing the external validity of the VALIDATE-SWEDEHEART trial 2021 ·Clinical Trials ·Rebecca Rylance, Philippe Wagner, Elmir Ömerovic, Claes Held, Stefan James, Sasha Koul, David Erlinge	1
8	Comparing Effect Estimates in Randomized Trials and Observational Studies From the Same Population: An Application to Percutaneous Coronary Intervention 2021 ·Journal of the American Heart Association ·Anthony Matthews, Karolina Szummer, Issa J Dahabreh, Bertil Lindahl, David Erlinge, Maria Feychting, Tomas Jernberg, Anita Berglund, Miguel A. Hernán	18
9	Outcome of PCI with Xience versus other commonly used modern drug eluting stents: A SCAAR report 2021 ·Catheterization and Cardiovascular Interventions ·Per Grimfjärd, (unknown), Sergio Buccheri, David Erlinge, Bo Lagerqvist, Bodil Svennblad, Sebastian Völz, Oskar Angerås, Stefan James	4
10	Helicobacter pylori screening in clinical routine during hospitalization for acute myocardial infarction 2020 ·American Heart Journal ·(unknown), (unknown), (unknown), (unknown), Sven‐Christian Pawelzik, David Erlinge, Tomas Jernberg, Stefan James, Robin Hofmann, Magnus Bäck	18
11	PROspective evaluation of coronary FLOW reserve and molecular biomarkers in patients with established coronary artery disease the PROFLOW-trial: cross-sectional evaluation of coronary flow reserve 2019 ·SHILAP Revista de lepidopterología ·Inger Haraldsson, (unknown), Sara Svedlund, (unknown), (unknown), Björn Redfors, Maria Lagerström‐Fermér, Oskar Angerås, Truls Råmunddal, Pétur Pétursson, Jacob Odenstedt, Per Albertsson, David Erlinge, Elmir Ömerovic	1
12	Oxygen Therapy in Myocardial Infarction Patients With or Without Diabetes: A Predefined Subgroup Analysis From the DETO2X-AMI Trial 2019 ·Diabetes Care ·Thomas Nyström, Stefan James, Bertil Lindahl, Ollie Östlund, David Erlinge, Johan Herlitz, Elmir Ömerovic, Linda Mellbin, Joakim Alfredsson, Ole Fröbert, Tomas Jernberg, Robin Hofmann	5
13	Pretreatment with ticagrelor may offset additional inhibition of platelet and coagulation activation with bivalirudin compared to heparin during primary percutaneous coronary intervention 2018 ·Thrombosis Research ·Dimitrios Venetsanos, Tomas Lindahl, Sofia Sederholm Lawesson, Kerstin M. Gustafsson, Håkan Wallén, David Erlinge, Eva Swahn, Joakim Alfredsson	3
14	Medical Therapy for Secondary Prevention and Long-Term Outcome in Patients With Myocardial Infarction With Nonobstructive Coronary Artery Disease breakdown → 2017 ·Circulation ·Bertil Lindahl, Tomasz Baron, David Erlinge, Nermin Hadziosmanovic, Anna Nordenskjöld, Anton Gard, Tomas Jernberg	309
15	Proteomics in Hypothermia as Adjunctive Therapy in Patients with ST-Segment Elevation Myocardial Infarction: A CHILL-MI Substudy 2017 ·Therapeutic Hypothermia and Temperature Management ·Moman A. Mohammad, (unknown), Iréne Lang, Michael Hölzer, Peter Clemmensen, Ulf Jensen, Bernhard Metzler, David Erlinge	8
16	Developing Clinical Trial in Acute Myocardial Infarction 2011 ·Therapeutic Hypothermia and Temperature Management ·Simon Dixon, Hans Friberg, Magnus Öhman, David Erlinge	1
17	A Review of Mild Hypothermia as an Adjunctive Treatment for ST-Elevation Myocardial Infarction 2011 ·Therapeutic Hypothermia and Temperature Management ·David Erlinge	23
18	Platelet transcriptional profile and protein expression in patients with systemic lupus erythematosus: up-regulation of the type I interferon system is strongly associated with vascular disease 2010 ·Blood ·Christian Lood, Stefan Amisten, Birgitta Gullstrand, Andreas Jönsen, Maria Allhorn, Lennart Truedsson, Gunnar Sturfelt, David Erlinge, Anders Bengtsson	157
19	Inhibition of c5a related neutrophil activation by adc-1004 reduces myocardial infarct in a porcine ischemia-reperfusion model 2010 ·Lund University Publications (Lund University) ·Jesper van der Pals, Sasha Koul, Patrik Gilje, Matthias Götberg, Joey F.A. Ubachs, Mikael Kanski, Håkan Arheden, Göran Olivecrona, B. Larsson, David Erlinge	1
20	Cellular Responses and Integrative Physiology 1998 ·Drug Development Research ·Dominique Hillaire‐Buys, J Chapal, Nathalie Linck, Jean‐Pierre Blayac, Pierre Petit, Mario Mariani, (unknown), Emil Pantev, David Erlinge	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact